CUSIP 69242L106COMMON STOCKOYSTQ4 2025
21 filings · latest Feb 14, 2023
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $11 |
| 4 | Jan 13, 2023 | Versant Venture Capital Vi, L.P. | 13D/A | — | — | SEC |
| 5 | Jan 9, 2023 | New Enterprise Associates 14, L.P. | 13D/A | — | — | SEC |
| 6 | Jan 5, 2023 | Invopps IV Us, L.P. | 13D/A | — | — | SEC |
| 7 | Dec 21, 2022 | Invopps IV Us, L.P. | 13D/A | 3.4% | 917.8K | SEC |
| 8 | Nov 21, 2022 | New Enterprise Associates 14, L.P. | 13D/A | 22.1% | 5.93M | SEC |
| 9 | Jul 18, 2022 | Paradigm Biocapital Advisors LP | 13G | 5.5% | 1.46M | SEC |
| 10 | Feb 14, 2022 | Rtw Investments, LP | 13G/A | 7.9% | 2.06M | SEC |
See the full Schedule 13D/13G history for Oyster Point Pharma Inc.
Unlock full history